Charlotte H.
- Country
- Denmark
- Department
- Oncology department
Research Overview
- Phase 3 Study Comparing Rinatabart Sesutecan Versus Investigator's Choice in Patients With Recurrent or Progressive Endometrial Cancer Following Platinum-Based and PD(L)-1 Therapy
- Phase 3 Randomized Controlled Trial of Adjuvant mRNA-4157 and Pembrolizumab Versus Placebo and Pembrolizumab in High-Risk Stage II-IV Melanoma
- Phase 3 Randomized Double-Blind Study of Niraparib Tosilate Monohydrate Maintenance in Advanced Ovarian Cancer Post-Platinum Chemotherapy Response
Data & Insights
Has run more than one trial at 113 of 274 partner sites.
Specializations
Gynecologic Oncology
The investigator specializes in treating advanced ovarian cancer and related malignancies, with particular focus on epithelial ovarian cancer, fallopian tube cancer, and peritoneal carcinoma.
- PARP inhibitor therapies
- Platinum-based treatment approaches
- Maintenance therapy strategies
Active involvement in evaluating novel therapeutic combinations including immunotherapy agents for recurrent and newly diagnosed cases.
Melanoma Research
The investigator conducts research in advanced melanoma treatment, focusing on both resectable and unresectable metastatic melanoma.
- Immunotherapy combinations
- Adjuvant treatment approaches
- Novel therapeutic agents
Expertise in implementing innovative immunotherapy protocols for various stages of melanoma.
Neuro-Oncology
The investigator focuses on treating glioblastoma and other brain malignancies, including diffuse gliomas with specific genetic mutations.
- Novel targeted therapies
- Post-surgical treatment approaches
- Combination therapy strategies
Specialized experience in managing both newly diagnosed and recurrent brain tumors.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.